SCHEMBL7261986

SCHEMBL7261986

COc1cc2c(N3CCSCC3)nc(-c3ccc(Cl)cc3)nc2c(OC)c1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.47
ALDH1A1 P00352 4/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
POLB P06746 1/20 0.47
KDM4E B2RXH2 3/20 0.44
STAT6 P42226 1/20 0.44
NTSR1 P30989 1/20 0.41
EGFR P00533 1/20 0.39
MTOR P42345 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
MAPT P10636 3/20 0.39
HPGD P15428 2/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
TSHR P16473 1/20 0.39
ALOX12 P18054 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7261507 0.87 ALDH1A1 (0.52) NPSR1ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL7267798 0.87 HTR3E (0.45) NPSR1ALDH1A1CYP1A2CYP2C19KDM4E
SCHEMBL8134950 0.85 KDM4E (0.43) NPSR1ALDH1A1KDM4ESTAT6NTSR1
SCHEMBL7262055 0.85 TGFBR1 (0.43) NPSR1ALDH1A1KDM4ESTAT6NTSR1
SCHEMBL7267789 0.85 KDM4E (0.43) NPSR1ALDH1A1KDM4ESTAT6NTSR1
SCHEMBL7267753 0.84 NPSR1 (0.63) NPSR1ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL7268539 0.84 NTSR1 (0.61) NPSR1ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL7261372 0.83 MAPT (0.46) NPSR1ALDH1A1KDM4ESTAT6NTSR1
SCHEMBL7261520 0.82 ACHE (0.53) NPSR1ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL5261786 0.82 ACHE (0.53) NPSR1ALDH1A1KDM4ESTAT6NTSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613772-B1 Drugs such as 2-(p-chlorophenyl-4-(4-hydroxybutyl)amino-6,7,8 -trimethoxyquinazoline used for activation of guanylate cyclase and modulation of cyclic guanosine monophosphate AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-02 US disclosed
EP-1040101-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Aventis Pharma Deutschland GmbH (DE) 2000-10-04 EP disclosed
WO-1999032460-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-07-01 WO disclosed